Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze data to uncover patterns primarily in the field of molecular diagnostics in the United States. The company's intellectual property include Support Vector Machines (SVM), which are mathematical algorithms that allow computers to sift through datasets to identify patterns; recursive feature elimination SVM that identifies and rank orders the data points that contribute the desired results; FGM, which enhances the mapping of genetic pathways involved in the diagnosis and prevention of certain diseases; and biomarkers, which are biological indicators or genetic expression signatures of certain disease states. It also develops a blood test for prostate cancer; and diagnostic test to interpret flow cell cytometry data for myelodysplastic syndrome, as well as provides an image analysis tool for cytogenetic analysis. The company holds a license agreement with NeoGenomics Laboratories, Inc. to develop and sell products in the laboratory testing, molecular diagnostics, clinical pathology, anatomic pathology, and digital image analysis fields. Health Discovery Corporation was founded in 2001 and is based in Atlanta, Georgia.
Industry, Sector and Symbol
Industry Patent owners & lessors
Sub-IndustryN/A
SectorMedical
Phone678-336-5300
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees3
Next Earnings DateN/A
OptionableNot Optionable
Health Discovery (OTCMKTS:HDVY) Frequently Asked Questions
What is Health Discovery's stock symbol?
Health Discovery trades on the OTCMKTS under the ticker symbol "HDVY."
Has Health Discovery been receiving favorable news coverage?
News articles about HDVY stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Health Discovery earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the company's share price in the next few days. View News Stories for Health Discovery.
Who are some of Health Discovery's key competitors?
What other stocks do shareholders of Health Discovery own?
Who are Health Discovery's key executives?
Health Discovery's management team includes the folowing people:
- Dr. Hong Zhang Ph.D., Sr. VP of Computational Medicine (Age 55)
- Dr. Mark A. Moore, VP of Product Devel. (Age 74)
- Mr. George H. McGovern III, Chairman & CEO
- Dr. Richard E. Caruso Ph.D., Founder and Sr. Advisor (Age 76)
How do I buy shares of Health Discovery?
Shares of HDVY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Health Discovery's stock price today?
One share of HDVY stock can currently be purchased for approximately $0.07.
What is Health Discovery's official website?
How can I contact Health Discovery?
Health Discovery's mailing address is 4243 Dunwoody Club Drive Suite 202, Atlanta GA, 30350. The company can be reached via phone at 678-336-5300 or via email at [email protected]
MarketBeat Community Rating for Health Discovery (OTCMKTS HDVY)
MarketBeat's community ratings are surveys of what our community members think about Health Discovery and other stocks. Vote "Outperform" if you believe HDVY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HDVY will underperform the S&P 500 over the long term. You may vote once every thirty days.
